BioNTech SE Files 6-K Report
Ticker: BNTX · Form: 6-K · Filed: Apr 13, 2026 · CIK: 0001776985
| Field | Detail |
|---|---|
| Company | Biontech Se (BNTX) |
| Form Type | 6-K |
| Filed Date | Apr 13, 2026 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: regulatory-filing, foreign-issuer
TL;DR
BioNTech filed a 6-K on 4/13/26, standard foreign issuer report.
AI Summary
BioNTech SE filed a Form 6-K on April 13, 2026, reporting information as a foreign issuer. The filing includes standard documents like the 6-K form itself and an exhibit labeled EX-99. The company's mailing and business addresses are both listed as AN DER GOLDGRUBE 12, MAINZ 2M 55131.
Why It Matters
This filing provides routine updates and disclosures for BioNTech SE as a foreign issuer, which is important for investors tracking the company's regulatory compliance and operational information.
Risk Assessment
Risk Level: low — This is a routine filing for a foreign issuer and does not appear to contain significant new financial or operational information that would immediately impact risk.
Key Players & Entities
- BioNTech SE (company) — Filer
- 0001776985 (company) — CIK
- 2026-04-13 (date) — Filing Date
- AN DER GOLDGRUBE 12 MAINZ 2M 55131 (address) — Mailing and Business Address
FAQ
What type of report is this 6-K filing?
This is a Report of foreign issuer filed under Rules 13a-16 and 15d-16.
When was this 6-K filing accepted by the SEC?
The filing was accepted on April 13, 2026.
What are the listed addresses for BioNTech SE?
The mailing and business addresses are both listed as AN DER GOLDGRUBE 12, MAINZ 2M 55131.
What is BioNTech SE's CIK number?
BioNTech SE's CIK number is 0001776985.
What is the SIC code for BioNTech SE?
The SIC code is 2836, categorized under Biological Products, (No Diagnostic Substances).
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on April 13, 2026 regarding BioNTech SE (BNTX).